Share on LinkedInShare on LinkedIn

ARTICLE · 19 DECEMBER 2012

Are Human Genes Patentable?

As reported in my November 30th, 2012 post, the U.S. Supreme Court granted certiorari to review the issue "are human genes patentable?"

United StatesIntellectual Property

As reported in my November 30th, 2012 post, the U.S. Supreme Court granted certiorari to review the issue "are human genes patentable?" The issue arises from the long-running dispute among a consortium of plaintiffs, led by the American Civil Liberties Union (collectively "ACLU") who sued Myriad Genetics, Inc. and the Directors of the University of of Utah Research Foundation (collectively "Myriad") challenging the patentability of composition and method claims related to human genetics. The Supreme Court's opinion has the potential to overrule over 30 years USPTO practice that supported the growth of the U.S. biotechnology industry.

The Appealed Patent Claims

The case started when the ACLU sought a declaration that 15 claims from seven patents assigned to Myriad were drawn to patent-ineligible subject matter under 35 U.S.C. section 101. The challenged composition claims cover two isolated human genes, BRCA1 and BRCA2 (collectively "BRACA1/2″ or "BRCA") and

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from